Key Developments: Cardinal Health Inc (CAH)
47.96USD
21 May 2013
$-0.06 (-0.12%)
$47.79
$48.09
$48.30
$47.74
3,424,947
3,583,296
$48.40
$36.91
Latest Key Developments (Source: Significant Developments)
Cardinal Health Inc Raises FY 2013 EPS Guidance
Cardinal Health Inc raised fiscal 2013 outlook for non-GAAP diluted EPS from continuing operations to $3.67 to $3.71. The revised range includes the $0.18 tax settlement previously mentioned. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $3.50 for fiscal 2013. Full Article
Cardinal Health Inc Raises Quarterly Dividend By 10%
Cardinal Health Inc announced that its board of directors approved a 10% increase in the Company's quarterly dividend to $0.3025 per share, or $1.21 per share on an annualized basis. The quarterly dividend is payable on July 15, 2013 to shareholders of record at close of business on July 1, 2013. Full Article
Cardinal Health Inc To Acquire AssuraMed
Cardinal Health Inc announced plans to acquire privately held AssuraMed, provider of medical supplies to patients in the home, for $2.07 billion, or $1.94 billion, net of the present value of tax benefits. The acquisition will be financed with a combination of $1.3 billion in new senior unsecured notes and the remainder in cash. The transaction is expected to close by early April 2013. After the transaction is complete, Cardinal Health will supply the home health care channel with product lines including ostomy, diabetes, insulin therapy, urological, wound care and incontinence. Full Article
Cardinal Health Inc Approves Quarterly Dividend
Cardinal Health Inc announced that board of directors approved a cash dividend of $0.275 per common share payable on April 15, 2013, to shareholders of record on April 1, 2013. This is the 114th consecutive regular quarterly dividend. Full Article
Cardinal Health Inc Raises Low End Of Prior FY 2013 EPS Guidance
Cardinal Health Inc tightened fiscal 2013 outlook for non-GAAP diluted EPS from continuing operations to $3.42 to $3.50, which represents the top half of the prior guidance range. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $3.45 for fiscal 2013. Full Article
Cardinal Health Inc To Sell Plants In Texas, Illinois; Announces Job Cuts And Reorganization Of Operations-Reuters
Reuters reported that Cardinal Health Inc said it would sell its procedure kits manufacturing facility in Waukegan, Illinois and its sterilization processes operations in El Paso, Texas as part of a restructuring of its medical business. Cardinal Health will move surgical kit production work from Illinois to plants in Juarez, Mexico and Fort Mill, South Carolina. The restructuring will also include a reorganization of the Company's sales operation and marketing teams. The Company said it would cut 180 positions as part of the restructuring and take a related charge of about $79 million. Full Article
Cardinal Health Inc Reaffirms FY 2013 EPS Guidance
Cardinal Health Inc reaffirmed its fiscal 2013 outlook for non-GAAP diluted EPS from continuing operations of $3.35 to $3.50. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $3.45 for fiscal 2013. Full Article
Cardinal Health Inc Raises Quarterly Dividend
Cardinal Health Inc announced that its Board of Directors has approved a 16% increase in the Company's quarterly dividend to $0.275 per share, or $1.10 per share on an annualized basis. The quarterly dividend is payable on January 15, 2013, to shareholders of record at the close of business on January 2, 2013. Full Article
Cardinal Health, Inc. Approves Cash Dividend; Authorizes New $750 Million Share Repurchase Program
Cardinal Health, Inc. announced that its Board of Directors approved a cash dividend of $0.2375 per share payable on October 15, 2012 to shareholders of record on October 1, 2012. The Board of Directors also approved a new, three-year authorization to repurchase up to $750 million of Cardinal Health common shares. This replaces the $750 million authorization approved in November 2010, of which $200 million remained. The new share repurchase authorization is effective immediately and expires August 31, 2015. Full Article
Cardinal Health, Inc. Issues FY 2013 EPS Guidance Below Analysts' Estimates
Cardinal Health, Inc. announced that for fiscal 2013, it expects non-GAAP diluted EPS from continuing operations (EPS) in the range of $3.35-$3.50. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $3.54 for fiscal 2013. Full Article
Walgreen to buy stake in AmerisourceBergen, Cardinal loses out
- Walgreen Co and partner Alliance Boots said on Tuesday they signed a 10-year deal with AmerisourceBergen that will include daily drug distribution, enabling Walgreen to increase its sales of pricey specialty drugs.
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
